Canada Vaccines Market to 2032
Overview
The Canada Vaccines Market is expected to reach a 2,885.17 USD Billion by 2032 and is projected to grow at a CAGR of 9.53% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,741.52
Forecast, 2032 (USD Billion)
2,885.17
CAGR, 2024 - 2032
9.53%
Report Coverage
Canada
Canada Vaccines Market 2018-2032 USD Billion
Canada Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,741.52 USD Billion
- Projected Market Size (2032): 2,885.17 USD Billion
- CAGR (2025-2032): 9.53%
Key Findings of Canada Vaccines Market
- The Canada Vaccines Market was valued at 1,741.52 USD Billion in 2024.
- The Canada Vaccines Market is likely to grow at a CAGR of 9.53% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 1,433.25 USD Billion
- The fastest growing segment Typhoid in Diseases Segment grew Fastest with a CAGR of 11.48% during the forecast period from 2024 to 2032.
Canada Vaccines Market Scope
Canada Vaccines Market Segmentation & Scope
Composition
- Mono Vaccines
- Combination Vaccines
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Route of Administration
- Nasal
- Oral
- Injectable
Canada Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,741.52 USD Billion |
| Market Value in 2032 | 2,885.17 USD Billion |
| CAGR (2025-2032) | 9.53% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Composition,Type,Age of Administration,Kind,Diseases,Distribution Channel,End User,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): Canada, leading in terms of revenue 1,741.52 USD Billion in 2024
- Key Country: Canada, leading in terms of revenue with value of 1,741.52 USD Billion in 2024.
Segments and Scope
-
Canada Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in Canada Vaccines Market to 2032 with a revenue of 1,379.24 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 9.77 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in Canada Vaccines Market to 2032 with a revenue of 677.95 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 10.26 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in Canada Vaccines Market to 2032 with a revenue of 989.79 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 9.40 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in Canada Vaccines Market to 2032 with a revenue of 1,178.92 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 9.06 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in Canada Vaccines Market to 2032 with a revenue of 277.44 USD Billion in the year 2024.
- Typhoid is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 10.44 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Canada Vaccines Market to 2032 with a revenue of 1,065.04 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 8.90 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in Canada Vaccines Market to 2032 with a revenue of 974.11 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 9.20 % in forecast period 2025-2032.
-
Canada Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in Canada Vaccines Market to 2032 with a revenue of 1,433.25 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Canada Vaccines Market to 2032 with a Growth rate of 9.70 % in forecast period 2025-2032.
Canada Vaccines Market Company Share Analysis
Canada Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
Canada Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada Vaccines Market is segmented based on Segmentation Composition,Type,Age of Administration,Kind,Diseases,Distribution Channel,End User,Route of Administration.
Canada Vaccines Market was valued at USD 1,741.52(Revenue in USD Billion) in 2020.
Canada Vaccines Market is projected to grow at a CAGR of 9.53% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Canada Vaccines Market, holding a largest market share of 1,433.25 USD Billion in 2024
Coming Soon....
Canada Vaccines Market Scope
Canada Vaccines Market Segmentation & Scope
Composition
- Mono Vaccines
- Combination Vaccines
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Route of Administration
- Nasal
- Oral
- Injectable
Frequently Asked Questions
The Canada Vaccines Market is segmented based on Segmentation Composition,Type,Age of Administration,Kind,Diseases,Distribution Channel,End User,Route of Administration.
Canada Vaccines Market was valued at USD 1,741.52(Revenue in USD Billion) in 2020.
Canada Vaccines Market is projected to grow at a CAGR of 9.53% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Vaccines Market for final year is USD 2,885.17 (USD Billion).
Canada Vaccines Market Company Profiling
Frequently Asked Questions
The Canada Vaccines Market is segmented based on Segmentation Composition,Type,Age of Administration,Kind,Diseases,Distribution Channel,End User,Route of Administration.
Canada Vaccines Market was valued at USD 1,741.52(Revenue in USD Billion) in 2020.
Canada Vaccines Market is projected to grow at a CAGR of 9.53% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Vaccines Market for final year is USD 2,885.17 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.